0001209191-22-021022.txt : 20220324
0001209191-22-021022.hdr.sgml : 20220324
20220324211009
ACCESSION NUMBER: 0001209191-22-021022
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220322
FILED AS OF DATE: 20220324
DATE AS OF CHANGE: 20220324
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Imran Talat
CENTRAL INDEX KEY: 0001869579
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40672
FILM NUMBER: 22768053
MAIL ADDRESS:
STREET 1: C/O RANI THERAPEUTICS HOLDINGS, INC.
STREET 2: 2051 RINGWOOD AVENUE
CITY: SAN JOSE
STATE: CA
ZIP: 95131
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Rani Therapeutics Holdings, Inc.
CENTRAL INDEX KEY: 0001856725
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2051 RINGWOOD AVENUE
CITY: SAN JOSE
STATE: CA
ZIP: 95131
BUSINESS PHONE: (408) 457-3700
MAIL ADDRESS:
STREET 1: 2051 RINGWOOD AVENUE
CITY: SAN JOSE
STATE: CA
ZIP: 95131
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-03-22
0
0001856725
Rani Therapeutics Holdings, Inc.
RANI
0001869579
Imran Talat
C/O RANI THERAPEUTICS LLC
2051 RINGWOOD AVE.
SAN JOSE
CA
95131
1
1
0
0
Chief Executive Officer
Class A Common Stock
2022-03-22
4
A
0
86600
0.00
A
98943
D
Stock Option (Right to Buy)
13.21
2022-03-22
4
A
0
263400
0.00
A
2032-03-21
Class A Common Stock
263400
263400
D
The shares subject to the restricted stock unit grant vest as follows: 25% of the RSUs shall vest yearly over four years from March 22, 2022.
The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from March 22, 2022.
/s/ Josh Seidenfeld, Attorney-in-Fact for Talat Imran
2022-03-24